Bezafibrate reduces blood glucose in type 2 diabetes mellitus
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 49 (3) , 331-334
- https://doi.org/10.1016/s0026-0495(00)90176-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Peroxisome Proliferator-Activated Receptor α (PPARα) Regulates the Plasma Thiobarbituric Acid-Reactive Substance (TBARS) LevelBiochemical and Biophysical Research Communications, 1997
- Relationship between circulating leptin and peripheral fat distribution in obese subjectsInternational Journal of Obesity, 1997
- Modulation of Insulin Activities by LeptinScience, 1996
- Effect of troglitazone on leptin production. Studies in vitro and in human subjectsDiabetes, 1996
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.Journal of Clinical Investigation, 1996
- Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissueDiabetes, 1995
- Tumor necrosis factor alpha: a key component of the obesity-diabetes linkDiabetes, 1994
- Prospective analysis of the insulin-resistance syndrome (syndrome X)Diabetes, 1992
- Lowering of Plasma Glucose Concentrations With Bezafibrate in Patients With Moderately Controlled NIDDMDiabetes Care, 1990